Brief: Volition Signs First Ever Nu.Q Vet Cancer Test Automation Agreement With Fujifilm Vet Systems
13/03/2025 14:40
March 13 (Reuters) - VolitionRX Ltd VNRX.A: VOLITION SIGNS FIRST EVER NU.Q® VET CANCER TEST AUTOMATION AGREEMENT WITH FUJIFILM VET SYSTEMS Source text: ID:nPnc2FrYva Further company coverage: VNRX.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems